121 related articles for article (PubMed ID: 8761440)
1. The BN rat strain carries dominant hepatocarcinogen resistance loci.
Pascale RM; Simile MM; DeMiglio MR; Muroni MR; Gaspa L; Dragani TA; Feo F
Carcinogenesis; 1996 Aug; 17(8):1765-8. PubMed ID: 8761440
[TBL] [Abstract][Full Text] [Related]
2. Resistance to the promotion of glutathione S-transferase 7-7-positive liver lesions in Copenhagen rats.
Wood GA; Sarma DS; Archer MC
Carcinogenesis; 1999 Jul; 20(7):1169-75. PubMed ID: 10383886
[TBL] [Abstract][Full Text] [Related]
3. Resistance of Copenhagen rats to chemical induction of glutathione S-transferase 7-7-positive liver foci.
Wood GA; Korkola JE; Lee VM; Sarma DS; Archer MC
Carcinogenesis; 1997 Sep; 18(9):1745-50. PubMed ID: 9328170
[TBL] [Abstract][Full Text] [Related]
4. Identification of genetic loci controlling hepatocarcinogenesis on rat chromosomes 7 and 10.
De Miglio MR; Canzian F; Pascale RM; Simile MM; Muroni MR; Calvisi D; Romeo G; Feo F
Cancer Res; 1999 Sep; 59(18):4651-7. PubMed ID: 10493520
[TBL] [Abstract][Full Text] [Related]
5. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain.
De Miglio MR; Simile MM; Muroni MR; Pusceddu S; Calvisi D; Carru A; Seddaiu MA; Daino L; Deiana L; Pascale RM; Feo F
Mol Carcinog; 1999 May; 25(1):21-9. PubMed ID: 10331741
[TBL] [Abstract][Full Text] [Related]
6. Genetic properties for the suppression of development of putative preneoplastic glutathione S-transferase placental form-positive foci in the liver of carcinogen-resistant DRH strain rats.
Denda A; Kitayama W; Konishi Y; Yan Y; Fukamachi Y; Miura M; Gotoh S; Ikemura K; Abe T; Higashi T; Higashi K
Cancer Lett; 1999 Jun; 140(1-2):59-67. PubMed ID: 10403542
[TBL] [Abstract][Full Text] [Related]
7. Strain differences in susceptibility to 2-acetylaminofluorene and phenobarbital promotion of rat hepatocarcinogenesis in a medium-term assay system: quantitation of glutathione S-transferase P-positive foci development.
Asamoto M; Tsuda H; Kagawa M; de Camargo JL; Ito N; Nagase S
Jpn J Cancer Res; 1989 Oct; 80(10):939-44. PubMed ID: 2515178
[TBL] [Abstract][Full Text] [Related]
8. Different inhibitory effects in the early and late phase of treatment with KAT-681, a liver-selective thyromimetic, on rat hepatocarcinogenesis induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
Hayashi M; Tamura T; Kuroda J; Ohnota H; Shibata N; Akahane M; Kashida Y; Mitsumori K
Toxicol Sci; 2005 Mar; 84(1):22-8. PubMed ID: 15564315
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent induction of preneoplastic liver cell foci by 2-acetylaminofluorene, phenobarbital and acetaminophen in F344 rats initially treated with diethylnitrosamine.
Hasegawa R; Takahashi S; Imaida K; Yamaguchi S; Shirai T; Ito N
Jpn J Cancer Res; 1991 Mar; 82(3):293-7. PubMed ID: 1902451
[TBL] [Abstract][Full Text] [Related]
10. Inheritance of resistance to promotion of preneoplastic liver lesions in Copenhagen rats.
Wood GA; Sarma DS; Archer MC
Exp Biol Med (Maywood); 2001 Oct; 226(9):831-5. PubMed ID: 11568305
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
Hayashi M; Ohnota H; Tamura T; Kuroda J; Shibata N; Akahane M; Moriwaki H; Machida N; Mitsumori K
Arch Toxicol; 2004 Aug; 78(8):460-6. PubMed ID: 15034639
[TBL] [Abstract][Full Text] [Related]
12. Mapping a sex hormone-sensitive gene determining female resistance to liver carcinogenesis in a congenic F344.BN-Hcs4 rat.
De Miglio MR; Virdis P; Calvisi DF; Frau M; Muroni MR; Simile MM; Daino L; Careddu GM; Sanna-Passino E; Pascale RM; Feo F
Cancer Res; 2006 Nov; 66(21):10384-90. PubMed ID: 17079458
[TBL] [Abstract][Full Text] [Related]
13. Reduction of glutathione S-transferase P-form mRNA expression in remodeling nodules in rat liver revealed by in situ hybridization.
Imai T; Masui T; Ichinose M; Nakanishi H; Yanai T; Masegi T; Muramatsu M; Tatematsu M
Carcinogenesis; 1997 Mar; 18(3):545-51. PubMed ID: 9067555
[TBL] [Abstract][Full Text] [Related]
14. Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis.
De Miglio MR; Pascale RM; Simile MM; Muroni MR; Calvisi DF; Virdis P; Bosinco GM; Frau M; Seddaiu MA; Ladu S; Feo F
Cancer Res; 2002 Aug; 62(15):4459-63. PubMed ID: 12154055
[TBL] [Abstract][Full Text] [Related]
15. Modulation of diethylnitrosamine-initiated placental glutathione S-transferase positive preneoplastic and neoplastic lesions by clofibrate, a hepatic peroxisome proliferator.
Hosokawa S; Tatematsu M; Aoki T; Nakanowatari J; Igarashi T; Ito N
Carcinogenesis; 1989 Dec; 10(12):2237-41. PubMed ID: 2686852
[TBL] [Abstract][Full Text] [Related]
16. Resistance of DRH strain rats to chemical carcinogenesis of liver: genetic analysis of later progression stage.
Yan Y; Zeng ZZ; Higashi S; Denda A; Konishi Y; Onishi S; Ueno H; Higashi K; Hiai H
Carcinogenesis; 2002 Jan; 23(1):189-96. PubMed ID: 11756240
[TBL] [Abstract][Full Text] [Related]
17. Behavioral assessment of aging in male Fischer 344 and brown Norway rat strains and their F1 hybrid.
Spangler EL; Waggie KS; Hengemihle J; Roberts D; Hess B; Ingram DK
Neurobiol Aging; 1994; 15(3):319-28. PubMed ID: 7936056
[TBL] [Abstract][Full Text] [Related]
18. Modulation of genetic resistance to hepatocarcinogenesis in DRH rats by partial hepatectomy.
Liu H; Nobumoto K; Yamada Y; Higashi K; Hiai H
Cancer Lett; 2003 Jun; 196(1):13-6. PubMed ID: 12860283
[TBL] [Abstract][Full Text] [Related]
19. Delayed effects of tamoxifen in hepatocarcinogenesis-resistant Fischer 344 rats as compared with susceptible strains.
Stanley LA; Carthew P; Davies R; Higginson F; Martin E; Styles JA
Cancer Lett; 2001 Sep; 171(1):27-35. PubMed ID: 11485825
[TBL] [Abstract][Full Text] [Related]
20. Detailed low-dose study of 1,1-bis(p-chlorophenyl)-2,2,2- trichloroethane carcinogenesis suggests the possibility of a hormetic effect.
Sukata T; Uwagawa S; Ozaki K; Ogawa M; Nishikawa T; Iwai S; Kinoshita A; Wanibuchi H; Imaoka S; Funae Y; Okuno Y; Fukushima S
Int J Cancer; 2002 May; 99(1):112-8. PubMed ID: 11948501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
